Laìa Masvidal

887 citations
17 papers · 552 indexed · h-index 11
Topics
RNA modifications and cancer (4 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)Cystic Fibrosis Research Advances (3 papers)
Partner nations
SwedenSpainCanada

In The Last Decade

Laìa Masvidal

15 papers receiving 550 citations

Peers

Laìa Masvidal
Comparison fields: 5 of 64
  • Molecular Biology 340
  • Immunology 152
  • Oncology 89
  • Cancer Research 56
  • Epidemiology 55
Replace Anna L. Vestergaard with:
Anna L. Vestergaard Denmark
Masaki Magari Japan
Hannah Titheradge United Kingdom
Saumya Ramanathan United States
Jacquelyn A. Gorman United States
Daniela A Slavin Argentina
Laura A. Elenich United States
Jayeeta Ghose United States
Kristen L. Meerbrey United States
Charlotte Hellmich United Kingdom
Laìa Masvidal relative to Anna L. Vestergaard Denmark Anna L. Vestergaard's profile →
Citations per field
00.5×1.5×
Anna L. Vestergaard · 1×
Citations per year

Countries citing papers authored by Laìa Masvidal

Since Specialization
Citations

This map shows the geographic impact of Laìa Masvidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laìa Masvidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laìa Masvidal more than expected).

Fields of papers citing papers by Laìa Masvidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laìa Masvidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laìa Masvidal. The network helps show where Laìa Masvidal may publish in the future.

Co-authorship network of co-authors of Laìa Masvidal

This figure shows the co-authorship network connecting the top 25 collaborators of Laìa Masvidal. A scholar is included among the top collaborators of Laìa Masvidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laìa Masvidal. Laìa Masvidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 0
3 21
4 18
5 1
6 22
7 46
8 50
9 73
10 121
11 144
12 10
13 21
14 11
15 4
16 7
17 3

About Laìa Masvidal

Laìa Masvidal is a scholar working on Genetics, Molecular Biology and Parasitology, having authored 17 papers that have together received 552 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cystic Fibrosis Research Advances (3 papers). The work is most often cited by research in Immunology (152 citations), Molecular Biology (340 citations) and Cancer Research (56 citations). Laìa Masvidal has collaborated with scholars based in Sweden, Spain and Canada. Frequent co-authors include Ola Larsson, Ivan Topisirović, Luc Furic, Julie Lorent, Laura Hulea, Shuo Liang, Vincent van Hoef, Shannon McLaughlan, Preetika Balanathan and Valentina Gandin. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026